SEC 13F Intelligence

Point72 Europe (London) LLP / NVSN

Point72 Europe (London) LLP’s Novartis AG Position

Does Point72 Europe (London) LLP own Novartis AG (NVSN)? Not currently — the last reported position was 186.1K shares worth $23M in Q2 2025; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$23M
Q2 2025
Shares
186.1K
% of Portfolio
+0.87%
Quarters Held
3
position exited

Position History NVSN

Reported value by quarter
Q4 ’24: $10MQ4 ’24Q1 ’25: $11MQ1 ’25Q2 ’25: $23MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025186.1K$23M+0.87%
Q1 2025102.3K$11M+0.78%
Q4 2024105.8K$10M+0.60%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Point72 Europe (London) LLP’s full portfolio or all institutional holders of NVSN.